Skip to main content
Premium Trial:

Request an Annual Quote

FTC Wants More Information About BGI-Shenzhen Buy of Complete Genomics

NEW YORK (GenomeWeb News) – The US Federal Trade Commission has made a second request to Complete Genomics and BGI-Shenzhen requesting additional information about BGI's proposed $117.6 million purchase of Complete Genomics, the Mountain View, Calif-based sequencing services firm said in a document filed with the US Securities and Exchange Commission on Friday.

As a result, the waiting period applicable under the Hart-Scott-Rodino Antitrust Improvement Act of 1976 has been extended beyond the original date of 11:59 PM EDT Oct. 31. The waiting period will now expire at 11:59 ET on the 10th day after Complete Genomics and BGI comply with FTC's request.

Last month, BGI extended its tender offer for Complete Genomics to midnight Nov. 21. It originally was to expire midnight, Oct. 23.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.